Skip to content
Congress·In Committee·9 months ago

House Bill Would Require Written Scientific Justification for Overriding Vaccine Panel Recommendations

Also known as: Family Vaccine Protection Act

Legislative Progress

Filed
Review
House
Senate
President

Key Points

  • Puts the national vaccine advice panel into federal law and sets rules for how it works, including open public meetings.
  • Requires the health agency leader to adopt the panel’s vaccine recommendations unless they publicly explain, using peer‑reviewed science, why they disagree.
  • Speeds up review of new vaccines: the panel must look at a newly licensed vaccine by its next meeting and aim to make a recommendation within 90 days after the maker notifies the agency.
  • If federal health leaders go against the panel on vaccine use (including insurance coverage rules and the children’s vaccine program), they must publish their reason and notify key House and Senate committees within 48 hours.
  • Adds a science standard for changing the vaccine injury compensation table, saying removals or other changes must be backed by the best available scientific evidence; authorizes $2.8 million per year for 2026–2029 to run the panel.
HealthcareConsumer ProtectionMedicare Medicaid

Milestones

2 milestones2 actions
Jun 4, 2025House

Referred to the House Committee on Energy and Commerce.

Jun 4, 2025

Introduced in House

What Happens Next

Projected impacts based on AI analysis

After the bill is enacted

ACIP’s structure, open-meeting rules, and recordkeeping become fixed in federal law

You can more reliably expect public meetings, posted recommendations, and accessible records rather than rules changing only through internal agency decisions

Immediately after enactment for new recommendations

CDC Director begins using the new “adopt or publicly explain why not” process for ACIP recommendations

If federal leaders don’t follow an ACIP recommendation, you should see a written explanation posted publicly, with Congress notified within 48 hours

Ongoing after enactment when new vaccines are licensed

Newly approved vaccines must be reviewed by ACIP by the next regular meeting, with a target recommendation timeline after a company’s written notice

New vaccines (or new uses) may move faster from “approved” to “officially recommended,” which can affect when doctors, pharmacies, and coverage systems update

Each year after enactment

ACIP continues holding at least three meetings each calendar year, with extra timing rules when new vaccines first enter the market

More predictable scheduling for when vaccine guidance can change, which can reduce long gaps without updates

Starting in fiscal year 2026 (around Oct 2025–Sep 2026)

HHS can begin using authorized funds to support ACIP operations for fiscal year 2026

More staff and support can mean quicker publication, smoother meetings, and better public-facing guidance, but only if Congress actually funds it

Related News

4 articles

Source Information

Document Type

Congressional Bill

Official Title

Family Vaccine Protection Act

Bill NumberHR 3701
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Energy and Commerce.

Sponsor

Cosponsors

(75)
D: 75

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.